Chromothripsis in acute myeloid leukemia: biological features and impact on survivalMaria Chiara Fontana, Giovanni Martinelli, Giovanni Marconi et al.|Leukemia|2018Cited by 115
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemiaAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Ilaria Iacobucci et al.|Oncotarget|2016Cited by 42
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutationsGiorgia Simonetti, Giovanni Martinelli, Michela Tebaldi et al.|Leukemia|2021Cited by 37
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaIlaria Iacobucci, Giovanni Martinelli, Andrea Ghelli Luserna di Rorà et al.|Journal of Hematology & Oncology|2015Cited by 28
Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid LeukemiaAntonella Padella, Giovanni Martinelli, Giorgia Simonetti et al.|Cancers|2019Cited by 24